The role of mouse Akt2 in insulin-dependent suppression of adipocyte lipolysis in vivo

Diabetologia

Volumn 58, Issue 5, 2015, Pages 1063-1070

  Koren, Shlomit ^a   DiPilato, Lisa M ^a   Emmett, Matthew J ^a   Shearin, Abigail L ^a   Chu, Qingwei ^a   Monks, Bob ^a   Birnbaum, Morris J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PFIZER INC   (United States)

Author keywords

Adipose tissue; Akt2; Insulin; Lipolysis

Indexed keywords

AKT2 PROTEIN, MOUSE; ANTIDIABETIC AGENT; INSULIN; PROTEIN KINASE B;

ADIPOCYTE; ANIMAL; DRUG EFFECTS; GENETICS; INSULIN RESISTANCE; LIPOLYSIS; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADIPOCYTES; ANIMALS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPOLYSIS; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84939989055     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3532-9     Document Type: Article

References (39)

1. Jenkins AB, Storlien LH, Chisholm DJ, Kraegen EW (1988) Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo. J Clin Invest 82:293–299
2. Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267–2277
3. Ahmadian M, Duncan RE, Sul HS (2009) The skinny on fat: lipolysis and fatty acid utilization in adipocytes. Trends Endocrinol Metab 20:424–428
4. Ahmad F, Lindh R, Tang Y, Weston M, Degerman E, Manganiello VC (2007) Insulin-induced formation of macromolecular complexes involved in activation of cyclic nucleotide phosphodiesterase 3B (PDE3B) and its interaction with PKB. Biochem J 404:257–268
5. Berggreen C, Gormand A, Omar B, Degerman E, Goransson O (2009) Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. Am J Physiol Endocrinol Metab 296:E635–E646
6. Eriksson H, Ridderstrale M, Degerman E et al (1995) Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin. Biochim Biophys Acta 1266:101–107
7. Kitamura T, Kitamura Y, Kuroda S et al (1999) Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol 19:6286–6296
8. Snyder PB, Esselstyn JM, Loughney K, Wolda SL, Florio VA (2005) The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis. J Lipid Res 46:494–503
9. Taniguchi CM, Emanuelli B, Kahn CR (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85–96
10. Cho H, Mu J, Kim JK et al (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292:1728–1731
11. Garofalo RS, Orena SJ, Rafidi K et al (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 112:197–208
12. George S, Rochford JJ, Wolfrum C et al (2004) A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304:1325–1328
13. Choi SM, Tucker DF, Gross DN et al (2010) Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway. Mol Cell Biol 30:5009–5020
14. Leavens KF, Easton RM, Shulman GI, Previs SF, Birnbaum MJ (2009) Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab 10:405–418
15. Klein J, Fasshauer M, Ito M, Lowell BB, Benito M, Kahn CR (1999) beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J Biol Chem 274:34795–34802
16. Schultze SM, Jensen J, Hemmings BA, Tschopp O, Niessen M (2011) Promiscuous affairs of PKB/AKT isoforms in metabolism. Arch Physiol Biochem 117:70–77
17. Martinez-Botas J, Anderson JB, Tessier D et al (2000) Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 26:474–479
18. Tansey JT, Sztalryd C, Gruia-Gray J et al (2001) Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 98:6494–6499
19. Boden G (2001) Pathogenesis of type 2 diabetes. Insulin resistance. Endocrinol Metab Clin N Am 30:801–815
20. Savage DB, Petersen KF, Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87:507–520
21. Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461–2474
22. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789
23. Thiebaud D, DeFronzo RA, Jacot E et al (1982) Effect of long chain triglyceride infusion on glucose metabolism in man. Metab Clin Exp 31:1128–1136
24. Wijkander J, Landstrom TR, Manganiello V, Belfrage P, Degerman E (1998) Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase. Endocrinology 139:219–227
25. Liu X, Shi Y, Birnbaum MJ et al (2006) Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions. J Biol Chem 281:31380–31388
26. Chen WS, Xu PZ, Gottlob K et al (2001) Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15:2203–2208
27. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ (2001) Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276:38349–38352
28. Easton RM, Cho H, Roovers K et al (2005) Role for Akt3/protein kinase B gamma in attainment of normal brain size. Mol Cell Biol 25:1869–1878
29. Yang ZZ, Tschopp O, Hemmings-Mieszczak M et al (2003) Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 278:32124–32131
30. Goncalves MD, Pistilli EE, Balduzzi A et al (2010) Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition. PLoS One 5:e12707
31. Bae SS, Cho H, Mu J, Birnbaum MJ (2003) Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J Biol Chem 278:49530–49536
32. Wan M, Leavens KF, Saleh D et al (2011) Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. Cell Metab 14:516–527
33. Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D (2007) Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 6:208–216
34. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6:77–86
35. Wu X, Williams KJ (2012) NOX4 pathway as a source of selective insulin resistance and responsiveness. Arterioscler Thromb Vasc Biol 32:1236–1245
36. Biddinger SB, Kahn CR (2006) From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68:123–158
37. Brown MS, Goldstein JL (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7:95–96
38. Li S, Brown MS, Goldstein JL (2010) Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci U S A 107:3441–3446
39. Gonzalez E, Flier E, Molle D, Accili D, McGraw TE (2011) Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor. Proc Natl Acad Sci U S A 108:10162–10167